From A to ZeeCRO
Following the divestiture of its US Pharmaceutical Development Services business which included the rights to the AAIPharma name, AAIPharma Inc. has changed its name to ZeeCRO Inc.
ZeeCRO Inc. continues to provide early and late stage development services to its customers worldwide. These services include: Integrated early development services (EU), Pharmaceutical analysis (EU), Clinical trial supplies (EU, SA), Phase 1 (EU), Bioanalysis(NA, EU), Global clinical development services and Oncology development consulting.
The new global headquarters for ZeeCRO is located in Cary, North Carolina, USA.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
